Research progress on anti-VEGF therapy for retinal capillary in diabetic macular edema
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Anti-vascular endothelial growth factor(VEGF)agents are revolutionary in the treatment of retinal diseases, such as exudative age-related macular degeneration,diabetic retinopathy(DR), and retinal vein occlusion. Intravitreal injection of anti-VEGF agents can reduce macular edema significantly, but whether anti-VEGF therapy impairs retinal microcirculation and facilitates retinal vascular occlusion. This article reviews on the effect of anti-VEGF therapy on retinal capillary in diabetic macular edema, from three aspects of foveal avascular zones, areas of nonperfusion and retinal capillary density, using optical coherence tomography angiography(OCTA)and ultra-wide field fluorescein angiography(UWFA).

    Reference
    Related
    Cited by
Get Citation

Jin Li, Wei Zhao, Pei Yan. Research progress on anti-VEGF therapy for retinal capillary in diabetic macular edema. Guoji Yanke Zazhi( Int Eye Sci) 2019;19(1):66-68

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:August 09,2018
  • Revised:November 22,2018
  • Adopted:
  • Online: December 17,2018
  • Published: